About Severance Hospital, Yonsei University Health System; Pharmacy
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
2
Clinical Trials at Severance Hospital, Yonsei University Health System; Pharmacy
During the past decade, Severance Hospital, Yonsei University Health System; Pharmacy conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study To Evaluate the Efficacy and Safety Of Bevacizumab, and Associated Biomarkers, In Combination With Paclitaxel Compared With Paclitaxel Plus Placebo as First-line Treatment Of Patients With Her2-Negative Metastatic Breast Cancer
2012-08-27
2017-11-21
Completed
481
A Study of Alectinib (RO5424802) in Participants With Non-Small Cell Lung Cancer Who Have Anaplastic Lymphoma Kinase (ALK) Mutation and Failed Crizotinib Treatment
2013-06-20
2017-10-27
Completed
138
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Severance Hospital, Yonsei University Health System; Pharmacy
According to Clinical.Site data, the most researched conditions in "Severance Hospital, Yonsei University Health System; Pharmacy" are
"Metastatic Breast Cancer" (1 trials) and "Non-Small-Cell Lung Carcinoma" (1 trials). Many other conditions were trialed in "Severance Hospital, Yonsei University Health System; Pharmacy" in a lesser frequency.
Clinical Trials Intervention Types at Severance Hospital, Yonsei University Health System; Pharmacy
Most popular intervention types in "Severance Hospital, Yonsei University Health System; Pharmacy" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Alectinib" (1 trials), "Bevacizumab [Avastin]" (1 trials), "Erlotinib" (1 trials), "Paclitaxel" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Severance Hospital, Yonsei University Health System; Pharmacy
The vast majority of trials in "Severance Hospital, Yonsei University Health System; Pharmacy" are
2 trials for "All" genders.
Clinical Trials Status at Severance Hospital, Yonsei University Health System; Pharmacy
Currently, there are NaN active trials in "Severance Hospital, Yonsei University Health System; Pharmacy".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Severance Hospital, Yonsei University Health System; Pharmacy,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Severance Hospital, Yonsei University Health System; Pharmacy, 1 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".